Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress
- PMID: 19451411
- DOI: 10.1161/HYPERTENSIONAHA.109.133710
Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress
Abstract
Angiotensin II (Ang II) modulates vasomotor tone, cell growth, and extracellular matrix deposition. This study analyzed the effect of atorvastatin in the possible alterations induced by Ang II on structure and mechanics of mesenteric resistance arteries and the signaling mechanisms involved. Wistar rats were infused with Ang II (100 ng/kg per day, SC minipumps, 2 weeks) with or without atorvastatin (5 mg/kg per day). Ang II increased blood pressure and plasmatic malondialdehyde levels. Compared with controls, mesenteric resistance arteries from Ang II-treated rats showed the following: (1) decreased lumen diameter; (2) increased wall/lumen; (3) decreased number of adventitial, smooth muscle, and endothelial cells; (4) increased stiffness; (5) increased collagen deposition; and (6) diminished fenestrae area and number in the internal elastic lamina. Atorvastatin did not alter blood pressure but reversed all of the structural and mechanical alterations of mesenteric arteries, including collagen and elastin alterations. In mesenteric resistance arteries, Ang II increased vascular O(2)(.-) production and diminished endothelial NO synthase and CuZn/superoxide dismutase but did not modify extracellular-superoxide dismutase expression. Atorvastatin improved plasmatic and vascular oxidative stress, normalized endothelial NO synthase and CuZn/superoxide dismutase expression, and increased extracellular-superoxide dismutase expression, showing antioxidant properties. Atorvastatin also diminished extracellular signal-regulated kinase 1/2 activation caused by Ang II in these vessels, indicating an interaction with Ang II-induced intracellular responses. In vascular smooth muscle cells, collagen type I release mediated by Ang II was reduced by different antioxidants and statins. Moreover, atorvastatin downregulated the Ang II-induced NADPH oxidase subunit, Nox1, expression. Our results suggest that statins might exert beneficial effects on hypertension-induced vascular remodeling by improving vascular structure, extracellular matrix alterations, and vascular stiffness. These effects might be mediated by their antioxidant properties.
Similar articles
-
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G147-56. doi: 10.1152/ajpgi.00462.2007. Epub 2008 Dec 4. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19056767
-
Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids.Hypertension. 2009 Jun;53(6):1008-16. doi: 10.1161/HYPERTENSIONAHA.109.132258. Epub 2009 Apr 20. Hypertension. 2009. PMID: 19380610
-
Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.Eur J Pharmacol. 2008 Jul 28;589(1-3):188-93. doi: 10.1016/j.ejphar.2008.04.054. Epub 2008 May 5. Eur J Pharmacol. 2008. PMID: 18538762
-
Nitric oxide and oxidative stress in vascular disease.Pflugers Arch. 2010 May;459(6):923-39. doi: 10.1007/s00424-010-0808-2. Epub 2010 Mar 21. Pflugers Arch. 2010. PMID: 20306272 Review.
-
Intracellular angiotensin II as a regulator of muscle tone in vascular resistance vessels. Pathophysiological implications.Peptides. 2016 Apr;78:87-90. doi: 10.1016/j.peptides.2016.02.006. Epub 2016 Mar 2. Peptides. 2016. PMID: 26944358 Review.
Cited by
-
Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.Br J Pharmacol. 2013 Jun;169(3):554-66. doi: 10.1111/j.1476-5381.2012.02106.x. Br J Pharmacol. 2013. PMID: 22817606 Free PMC article.
-
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).J Cardiovasc Electrophysiol. 2011 Apr;22(4):414-9. doi: 10.1111/j.1540-8167.2010.01925.x. Epub 2010 Oct 13. J Cardiovasc Electrophysiol. 2011. PMID: 20946227 Free PMC article. Clinical Trial.
-
Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment.Biology (Basel). 2020 Mar 21;9(3):60. doi: 10.3390/biology9030060. Biology (Basel). 2020. PMID: 32245238 Free PMC article. Review.
-
The Comparison of Antioxidant Effect of Aspirin, Metformin, Atorvastatin and Captopril Co-administration in the Heart and Kidney Tissues of Diabetic Rats.Iran J Pharm Res. 2021 Winter;20(1):27-39. doi: 10.22037/ijpr.2019.112004.13481. Iran J Pharm Res. 2021. PMID: 34400938 Free PMC article.
-
Long-term effects of intensive multifactorial treatment on aortic stiffness and central hemodynamics after 13 years with screen-detected type 2 diabetes: the ADDITION-Denmark trial.Diabetol Metab Syndr. 2022 Aug 17;14(1):116. doi: 10.1186/s13098-022-00890-1. Diabetol Metab Syndr. 2022. PMID: 35978373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous